Journal profile · Medicine-Endocrinology, Diabetes and Metabolism
Diabetes & Metabolism Journal
ISSN 2233-6079 · eISSN 2233-6087 · Korean Diabetes Association · South Korea
Diabetes & Metabolism Journal: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 8.08; fully open access; APC about USD 500; median 115 days to acceptance (52 articles, last 24 months); 143 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Diabetes & Metabolism Journal is published by Korean Diabetes Association and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Diabetes, Cardiovascular Risks, and Lipoproteins, Diabetes Treatment and Management and Diabetes Management and Research, together about 35.8% of its articles. Its main subfields are Endocrinology, Diabetes and Metabolism. (generated from OpenAlex topic counts and CAS ranking data)
The aims of the Diabetes & Metabolism Journal are to contribute to the cure of and education about diabetes mellitus, and the advancement of diabetology through the sharing of scientific information on the latest developments in diabetology among members of the Korean Diabetes Association and other international societies. The Journal publishes articles on basic and clinical studies, focusing on areas such as metabolism, epidemiology, pathogenesis, complications, and treatments relevant to diabetes mellitus. It also publishes articles covering obesity and cardiovascular disease. Articles on translational research and timely issues including ubiquitous care or new technology in the management of diabetes and metabolic disorders are welcome. In addition, genome research, meta-analysis, and randomized controlled studies are welcome for publication. The editorial board invites articles from international research or clinical study groups. Publication is determined by the editors and peer reviewers, who are experts in their specific fields of diabetology.
Source: LetPub
Research area (LetPub): Medicine-Endocrinology, Diabetes and Metabolism
Editorial board by country: 5 in mainland China (about 5%); most named South Korea 42, United States 15, Japan 12, Hong Kong, China 6, Mainland China 5 (97 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Diabetes, Cardiovascular Risks, and LipoproteinsMedicine13.7%
- Diabetes Treatment and ManagementMedicine12.7%
- Diabetes Management and ResearchMedicine9.4%
- Pancreatic function and diabetesMedicine6.9%
- Metabolism, Diabetes, and CancerBiochemistry, Genetics and Molecular Biology5.6%
- Adipokines, Inflammation, and Metabolic DiseasesMedicine4.6%
- Diabetes and associated disordersBiochemistry, Genetics and Molecular Biology4.5%
- Diabetes Management and EducationMedicine4.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Endocrinology & Metabolism | Zone 2 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Endocrinology & Metabolism | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Endocrinology & Metabolism | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 8.08LetPub ·
- CiteScore 2026-06
- 15.6LetPub ·
- SJR 2026-06
- 2.96LetPub ·
- SNIP 2026-06
- 2.69LetPub ·
- h-index
- 36LetPub ·
- h-index
- 98OpenAlex ·
- i10-index
- 781OpenAlex ·
- 2-year mean citedness
- 7.33OpenAlex ·
- Self-citation rate
- 6.1%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 81LetPub ·
Articles by year OpenAlex count · 1,570 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 75 | 75 | 53 |
| 2025 | 143 | 143 | 903 |
| 2024 | 121 | 121 | 1,528 |
| 2023 | 84 | 84 | 1,852 |
| 2022 | 86 | 86 | 3,095 |
| 2021 | 103 | 103 | 4,614 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
115 daysMedian, submission to acceptance · P25–P75 68 days – 188 days
- Acceptance to online
- median 179 days (53 articles)
- Submission to online
- median 298 days
- Sample
- 52 articles with submission and acceptance dates (277 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 52 weeksLetPub ·
- Submission to publication (journal-reported)
- about 52 weeksDOAJ ·
- Peer review
- Unspecified peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 500 | Yes | CC BY-NC | |
| OpenAlex | USD 500 | — | — | |
| LetPub | USD 500 | Yes | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websiteSelf-archiving
- Self-archiving
Article sharing (author self-archiving) policy Model summary
Article sharing (author self-archiving) policy
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Korean Diabetes Association
- Country or region
- South Korea
- Language
- English
- ISSN
- 2233-6079
- Electronic ISSN
- 2233-6087
- Latest issue on the website
- Volume 50 (September 2026)
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
FAQ
Frequently asked questions about Diabetes & Metabolism Journal
What CAS zone is Diabetes & Metabolism Journal in?
In the 2025 upgraded edition of the CAS Journal Ranking, Diabetes & Metabolism Journal is in Zone 2 of Medicine, and in Zone 2 of the minor category Endocrinology & Metabolism. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Diabetes & Metabolism Journal?
The latest impact factor listed by LetPub is 8.08; CiteScore 15.6, h-index 98.
How long does peer review take at Diabetes & Metabolism Journal?
Based on the dates recorded on 52 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 115 days (interquartile range 68–188 days); authors report an average review time of about 52 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Diabetes & Metabolism Journal based?
Of the 97 board members whose country the journal's board page names, 5 (about 5%) are in mainland China; the countries named most often are South Korea (42), United States (15) and Japan (12). Counted from the institutions listed on the board page; for reference only.
Which databases index Diabetes & Metabolism Journal?
According to LetPub and DOAJ records, Diabetes & Metabolism Journal is indexed in SCIE, Scopus and DOAJ.
Is Diabetes & Metabolism Journal open access, and what is the APC?
Diabetes & Metabolism Journal is a fully open-access journal. APC about USD 500.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .